News
Regeneron Pharmaceuticals Announces FDA Approval for Higher-Dose Eylea Formulation
Shares of Regeneron Pharmaceuticals Inc. (REGN) gained 1.4% in premarket trading on Monday, following the company’s announcement late Friday that the U.S. Food ...